Tranylcypromine sulphate (Tranylcypromine sulphate)
Overview of Tranylcypromine sulphate
Tranylcypromine (Sulphate) is antidepressant agent, belongs to monoamino oxidase inhibitors. Tranylcypromine (Sulphate) is effective for the symptomatic relief of severe reactive or endogenous depression in patient who have not responded to other anti-depressant therapy.
Indication of Tranylcypromine sulphate
Tranylcypromine Sulphate is primarily indicated in conditions like Depression, Neurosis, Psychosis, and can also be given in adjunctive therapy as an alternative drug of choice in Anxiety, Phobias.
Contraindication of Tranylcypromine sulphate
Tranylcypromine (Sulphate) is contraindicated in conditions like Alcohol dependence,Hyperthyroidism,Phaeochromocytoma,Blood dyscrasias,Liver diseases,Cardiovascular disease,Cerebrovascular disease.
Side Effects of Tranylcypromine sulphate
The severe or irreversible adverse effects of Tranylcypromine (Sulphate), which give rise to further complications include Liver dysfunction.,Tranylcypromine (Sulphate) produces potentially life-threatening effects which include Severe sympathomimetic crisis. which are responsible for the discontinuation of Tranylcypromine (Sulphate) therapy.,The signs and symptoms that are produced after the acute overdosage of Tranylcypromine (Sulphate) include Tachycardia, Convulsions, Fever, Headache, Coma and death, Tachypnea, Agitation, Hypertension, Neuromuscular weakness, Mental confusion, Chest pain.,The symptomatic adverse reactions produced by Tranylcypromine (Sulphate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Headache, Drowsiness, Nausea, Restlessness, Palpitation, Weight gain, Peripheral neuropathy, Anticholinergic side effects.
Precautions of Tranylcypromine sulphate
Take adequate precautions when treating epileptic patients with tranylcypromine. It should be used with caution in patients with impaired renal (kidney) function and hyperthyroidism. Perform periodic liver function tests, discontinue use at the first sign of liver dysfunction or jaundice.